Kala Pharmaceuticals Adds 6% In Morning Trade

On:

Shares of Kala Pharmaceuticals, Inc. (KALA) are rising more than 6% Friday morning at $16.43.

The company today said Combangio, Inc., a unit of Kala, has been awarded a $15 million grant by the California Institute for Regenerative Medicine (CIRM) to support the company’s ongoing study of KPI-012 for the treatment of persistent corneal epithelial defect (PCED).

KALA has traded in the range of $3.54-$56.72 in the last 1 year.

Source: Read Full Article

Lates News:
  1. Dollar Tree Falls On Lower Quarterly Profit, Outlook Shy Of Estimates
  2. Bitcoin Enjoys Growing Favorable Conditions, Top Analyst Says
  3. Duckhorn Portfolio Falls As Co. Expects Annual Results Below View
  4. Bitcoin Holds Steady Above $22K Even As Elon Musk's Tesla Dumps 75% Of Its BTC Holdings
  5. Rate Hikes And Recession Fears Dampen Market Sentiment